Today marks the release of the sonic masterpiece Music for Psychedelic Therapy by musician Jon Hopkins. After attending a live ceremonial concert where...
Peyton Nyquvest is the CEO of Numinus, a Canadian publicly-traded company that is involved in psychedelic synthesis, research and treatment. Numinous recently...
The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies. The post Awakn Life Sciences’ Revenue...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, today announced upcoming event...
The article Mydecine Reports Positive Preclinical Results on MYCO-006 Short-Acting MDMA Analogues was originally published on Microdose. Mydecine Reports...
The article LSD Decreased Depression Symptoms by 50% in New MindMed Study was originally published on Microdose. On April 14th, psychedelic medicine company...
Psychedelics are safe for healthy older adults, a new review of clinical trials suggests, but few are included in research studies. The post Safety of...
The article Psychedelics and the Evolution of Mental Health Care was originally published on Microdose. In a post-pandemic era, it goes without saying...
As more cities and states decriminalize ibogaine, practitioners consider the unique challenges that make it difficult to incorporate into regulated frameworks...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, and PharmAla Biotech Holdings...